Dashboard
Manage Tickers

BIO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

citigroup-maintains-buy-on-bio-rad-laboratories-raises-price-target-to-375
Citigroup Maintains Buy on Bio-Rad Laborat...
10/30/2025 18:23:03

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and raises the price target from $35...

wells-fargo-maintains-equal-weight-on-bio-rad-laboratories-raises-price-target-to-340
Wells Fargo Maintains Equal-Weight on Bio-...
10/30/2025 14:45:37

Wells Fargo analyst Brandon Couillard maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weight and raises the price tar...

correction-bio-rad-laboratories-q3-adj-eps-226-beats-193-estimate-sales-653000m-beat-651301m-estimate
CORRECTION: Bio-Rad Laboratories Q3 Adj. E...
10/29/2025 21:41:56

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.26 per share which beat the analyst consensus estimate of $1....

bio-rad-laboratories-affirms-fy2025-sales-guidance-of-2567b-2593b-vs-2593b-est
Bio-Rad Laboratories Affirms FY2025 Sales ...
10/29/2025 20:18:49

Full-Year 2025 Financial OutlookBio-Rad is maintaining its financial outlook for the full year 2025. The company continues to e...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

bio-rad-laboratories-analysts-raise-their-forecasts-after-better-than-expected-q2-earnings
Bio-Rad Laboratories Analysts Raise Their ...
08/01/2025 15:30:23

rbc-capital-maintains-outperform-on-bio-rad-laboratories-raises-price-target-to-409
RBC Capital Maintains Outperform on Bio-Ra...
08/01/2025 15:23:26

RBC Capital analyst Conor McNamara maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and raises the price target f...

monolithic-power-systems-workiva-interface-appfolio-and-other-big-stocks-moving-higher-on-friday
Monolithic Power Systems, Workiva, Interfa...
08/01/2025 14:44:18

wells-fargo-maintains-equal-weight-on-bio-rad-laboratories-raises-price-target-to-265
Wells Fargo Maintains Equal-Weight on Bio-...
08/01/2025 14:18:03

Wells Fargo analyst Brandon Couillard maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weight and raises the price tar...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

bio-rad-laboratories-narrows-fy2025-sales-guidance-from-2541b-2606b-to-2567b-2593b-vs-2520b-est
Bio-Rad Laboratories Narrows FY2025 Sales ...
07/31/2025 20:20:20

Bio-Rad Laboratories (NYSE:BIO) narrows FY2025 sales outlook from $2.541 billion-$2.606 billion to $2.567 billion-$2.593 billio...

bio-rad-laboratories-q2-adj-eps-261-beats-176-estimate-sales-651600m-beat-615110m-estimate
Bio-Rad Laboratories Q2 Adj. EPS $2.61 Bea...
07/31/2025 20:15:43

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of $1....

Core News & Articles
Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

bio-rad--announces-launch-of-new-droplet-digital-pcr-platforms
Bio-Rad Announces Launch Of New Droplet D...
07/07/2025 13:02:13

5-analysts-have-this-to-say-about-bio-rad-laboratories
5 Analysts Have This To Say About Bio-Rad ...
06/09/2025 21:00:33

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
05/06/2025 17:35:25

ubs-maintains-buy-on-bio-rad-laboratories-lowers-price-target-to-310
UBS Maintains Buy on Bio-Rad Laboratories,...
05/02/2025 22:47:01

UBS analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and lowers the price target from $355 to $310.

citigroup-maintains-buy-on-bio-rad-laboratories-lowers-price-target-to-350
Citigroup Maintains Buy on Bio-Rad Laborat...
05/02/2025 22:12:21

Citigroup analyst Patrick Donnelly maintains Bio-Rad Laboratories (NYSE:BIO) with a Buy and lowers the price target from $40...

rbc-capital-maintains-outperform-on-bio-rad-laboratories-lowers-price-target-to-392
RBC Capital Maintains Outperform on Bio-Ra...
05/02/2025 18:38:36

RBC Capital analyst Conor McNamara maintains Bio-Rad Laboratories (NYSE:BIO) with a Outperform and lowers the price target f...

bio-rad-laboratories-sees-fy25-non-gaap-currency-neutral-revenue-to-rang-from-10-decline-to-15-growth
Bio-Rad Laboratories Sees FY25 Non-GAAP Cu...
05/01/2025 20:20:21

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION